Abstract
Paroxysmal supraventricular tachycardia (PSVT) is a frequently occurring arrhythmia. Currently, verapamil and manual vagal stimulation are the first- line interventions for PSVT. Although verapamil is widely used for the treatment of PSVT, it can result in hypotension and ventricular fibrillation if given to a patient with ventricular tachycardia. Because the differential diagnosis of broad QRS complex tachycardia is difficult, the development of a safer drug for the treatment of both narrow- and broad-complex tachycardia is extremely important. Adenosine is a promising new drug for the treatment of PSVT. Its use is reviewed in three presentations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 350-356 |
| Number of pages | 7 |
| Journal | Heart and Lung: Journal of Critical Care |
| Volume | 21 |
| Issue number | 4 |
| State | Published - Jan 1 1992 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine